BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34087693)

  • 1. Molecular targets for the management of gastrointestinal cancer using melatonin, a natural endogenous body hormone.
    Kohandel Z; Farkhondeh T; Aschner M; Samarghandian S
    Biomed Pharmacother; 2021 Aug; 140():111782. PubMed ID: 34087693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin as a treatment for gastrointestinal cancer: a review.
    Xin Z; Jiang S; Jiang P; Yan X; Fan C; Di S; Wu G; Yang Y; Reiter RJ; Ji G
    J Pineal Res; 2015 May; 58(4):375-87. PubMed ID: 25752643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin-induced demethylation of antioxidant genes increases antioxidant capacity through RORα in cumulus cells of prepubertal lambs.
    Fang Y; Zhang J; Li Y; Guo X; Li J; Zhong R; Zhang X
    Free Radic Biol Med; 2019 Feb; 131():173-183. PubMed ID: 30472366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nuclear receptor for melatonin represses 5-lipoxygenase gene expression in human B lymphocytes.
    Steinhilber D; Brungs M; Werz O; Wiesenberg I; Danielsson C; Kahlen JP; Nayeri S; Schräder M; Carlberg C
    J Biol Chem; 1995 Mar; 270(13):7037-40. PubMed ID: 7706239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential therapeutic actions of melatonin in colorectal cancer.
    Chok KC; Ng CH; Koh RY; Ng KY; Chye SM
    Horm Mol Biol Clin Investig; 2019 May; 39(1):. PubMed ID: 31141480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin for the prevention and treatment of cancer.
    Li Y; Li S; Zhou Y; Meng X; Zhang JJ; Xu DP; Li HB
    Oncotarget; 2017 Jun; 8(24):39896-39921. PubMed ID: 28415828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of melatonin and melatonin receptors ligand N-[(4-methoxy-1H-indol-2-yl)methyl]propanamide on murine Colon 38 cancer growth in vitro and in vivo.
    Winczyk K; Pawlikowski M; Lawnicka H; Kunert-Radek J; Spadoni G; Tarzia G; Karasek M
    Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():50-4. PubMed ID: 12019352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and Molecular Mechanisms of 3,3'-Diindolylmethane in Gastrointestinal Cancer.
    Kim SM
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27447608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible involvement of the nuclear RZR/ROR-alpha receptor in the antitumor action of melatonin on murine Colon 38 cancer.
    Winczyk K; Pawlikowski M; Guerrero JM; Karasek M
    Tumour Biol; 2002; 23(5):298-302. PubMed ID: 12595746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of androgen-sensitive LNCaP prostate cancer growth in vivo by melatonin: association of antiproliferative action of the pineal hormone with mt1 receptor protein expression.
    Xi SC; Siu SW; Fong SW; Shiu SY
    Prostate; 2001 Jan; 46(1):52-61. PubMed ID: 11170132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin modulates glucocorticoid receptor mediated inhibition of antioxidant response and apoptosis in peripheral blood mononuclear cells.
    Singh AK; Haldar C
    Mol Cell Endocrinol; 2016 Nov; 436():59-67. PubMed ID: 27452798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of natural monomeric response elements of the nuclear receptor RZR/ROR. They also bind COUP-TF homodimers.
    Schräder M; Danielsson C; Wiesenberg I; Carlberg C
    J Biol Chem; 1996 Aug; 271(33):19732-6. PubMed ID: 8702678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin membrane receptors in peripheral tissues: distribution and functions.
    Slominski RM; Reiter RJ; Schlabritz-Loutsevitch N; Ostrom RS; Slominski AT
    Mol Cell Endocrinol; 2012 Apr; 351(2):152-66. PubMed ID: 22245784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role of melatonin in prevention and treatment of leukaemia.
    Ng MG; Ng KY; Koh RY; Chye SM
    Horm Mol Biol Clin Investig; 2021 Aug; 42(4):445-461. PubMed ID: 34355548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin promotes ATO-induced apoptosis in MCF-7 cells: Proposing novel therapeutic potential for breast cancer.
    Nooshinfar E; Bashash D; Safaroghli-Azar A; Bayati S; Rezaei-Tavirani M; Ghaffari SH; Akbari ME
    Biomed Pharmacother; 2016 Oct; 83():456-465. PubMed ID: 27427852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin enhances the apoptotic effects and modulates the changes in gene expression induced by docetaxel in MCF‑7 human breast cancer cells.
    Alonso-González C; Menéndez-Menéndez J; González-González A; González A; Cos S; Martínez-Campa C
    Int J Oncol; 2018 Feb; 52(2):560-570. PubMed ID: 29207126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the expression of melatonin receptors induced by melatonin treatment in hepatocarcinoma HepG2 cells.
    Carbajo-Pescador S; Martín-Renedo J; García-Palomo A; Tuñón MJ; Mauriz JL; González-Gallego J
    J Pineal Res; 2009 Nov; 47(4):330-8. PubMed ID: 19817970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin and RZR/ROR receptor ligand CGP 52608 induce apoptosis in the murine colonic cancer.
    Winczyk K; Pawlikowski M; Karasek M
    J Pineal Res; 2001 Sep; 31(2):179-82. PubMed ID: 11555175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis is triggered by melatonin in an in vivo model of ovarian carcinoma.
    Chuffa LG; Alves MS; Martinez M; Camargo IC; Pinheiro PF; Domeniconi RF; Júnior LA; Martinez FE
    Endocr Relat Cancer; 2016 Feb; 23(2):65-76. PubMed ID: 26555801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin and gastrointestinal cancers: Current evidence based on underlying signaling pathways.
    Pourhanifeh MH; Mehrzadi S; Kamali M; Hosseinzadeh A
    Eur J Pharmacol; 2020 Nov; 886():173471. PubMed ID: 32877658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.